|
International Prices And Availability Of Pharmaceuticals In 2005
Patricia M. Danzon and
Michael F. Furukawa
This paper compares pharmaceutical spending, availability, use, and prices in twelve countries in 2005. Drug spending per capita was higher in the United States than in other countries. The United States had relatively high use of new drugs and high-strength formulations; other countries used more of older drugs and weaker formulations. Thus, whether U.S. overall volume of use is lower or higher depends on the measure of volume and type of product. Comprehensive price indexes show foreign prices to be 20–40 percent lower than U.S. manufacturer prices, but only 10–30 percent lower than U.S. public prices. Generics are cheaper in the United States than in other countries.
       What's this?
This article has been cited by other articles:
|
|
|
|
 
H. J. Aaron and P. B. Ginsburg
Is Health Spending Excessive? If So, What Can We Do About It?
Health Aff.,
September 1, 2009;
28(5):
1260 - 1275.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
M. K. Bundorf, A. Royalty, and L. C. Baker
Health Care Cost Growth Among The Privately Insured
Health Aff.,
September 1, 2009;
28(5):
1294 - 1304.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
P. T Sawicki and H. Bastian
German health care: a bit of Bismarck plus more science
BMJ,
November 7, 2008;
337(nov07_1):
a1997 - a1997.
[Full Text]
|
|
|
|
|
|
|
E. J. Emanuel and V. R. Fuchs
The Perfect Storm of Overutilization
JAMA,
June 18, 2008;
299(23):
2789 - 2791.
[Full Text]
[PDF]
|
|
|
|
